Salvage Treatment with Boceprevir-based Triple Therapy aft er Failed Treatment of Acute Hepatitis C with Dual Therapy

被引：0
|
作者：
Mansour, Nabil [1 ]
El-Halabi, Mustapha [1 ]
Salyers, William [1 ]
机构：
[1] Univ Kansas, Sch Med Wichita, Wichita, KS USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2013年 / 108卷
关键词：
D O I：
10.14309/00000434-201310001-01104
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1104
引用
收藏
页码：S328 / S328
页数：1
相关论文
共 50 条
  • [1] Effectiveness of telaprevir/boceprevir-based triple therapy for chronic hepatitis c
    Garcia-Queiruga, Marta
    Purificacion, Cid
    Laura Maria, Martinez-Lopez
    Marta, Leston
    Luis, Margusino
    Isabel, Martin
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 280 - 281
  • [2] Treatment safety and efficacy of boceprevir-based triple therapy in genotype 1 hepatitis C: the Australian multicenter boceprevir real world experience (SABRE-C)
    Dev, A.
    Mitchell, J.
    Polkinghorne, K.
    Skoien, R.
    Stuart, K.
    Cheng, W.
    Lee, A.
    Levy, M.
    Lubel, J.
    Nazareth, S.
    Warner, S.
    Wigg, A.
    Roberts, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 70 - 70
  • [3] Predictors of early treatment discontinuation in a cohort of patients treated with boceprevir-based therapy for hepatitis C infection
    Majid, A.
    McAninch, J.
    Morgan, D. J.
    El Kamary, S. S.
    Zhan, M.
    Kapelusznik, L.
    Talwani, R.
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 (08) : 585 - 589
  • [4] Factors associated with success of telaprevir-and boceprevir-based triple therapy for hepatitis C virus infection
    Kian Bichoupan
    Neeta Tandon
    Valerie Martel-Laferriere
    Neal M Patel
    David Sachs
    Michel Ng
    Emily A Schonfeld
    Alexis Pappas
    James Crismale
    Alicia Stivala
    Viktoriya Khaitova
    Donald Gardenier
    Michael Linderman
    William Olson
    Ponni V Perumalswami
    Thomas D Schiano
    Joseph A Odin
    Lawrence U Liu
    Douglas T Dieterich
    Andrea D Branch
    World Journal of Hepatology, 2017, 9 (11) : 551 - 561
  • [5] Treatment safety and efficacy of Boceprevir-based triple therapy in genotype 1 hepatitis C: the Australian multi-centre Boceprevir real world experience (SABRE-C)
    Dev, Anouk T.
    Mitchell, Joanne
    Polkinghorne, Kevan
    Skoien, Richard
    Stuart, Katherine
    Cheng, Wendy
    Lee, Alice
    Levy, Miriam T.
    Lubel, John
    Nazareth, Saroja
    Wigg, Alan J.
    Warner, Sherryne L.
    Roberts, Stuart K.
    HEPATOLOGY, 2014, 60 : 674A - 674A
  • [6] Boceprevir-Based Triple Antiviral Therapy for Chronic Hepatitis C Virus Infection in Kidney-Transplant Candidates
    Mehawej, Mireille
    Rostaing, Lionel
    Alric, Laurent
    Del Bello, Arnaud
    Izopet, Jacques
    Kamar, Nassim
    JOURNAL OF TRANSPLANTATION, 2015, 2015
  • [7] Boceprevir-based triple therapy for belgian liver transplant patients infected with hepatitis C virus: A preliminary experience
    Degre, Delphine
    Colle, Isabelle
    Van Vlierberghe, Hans
    Moreno, Christophe
    LIVER TRANSPLANTATION, 2013, 19 (06) : 669 - 670
  • [8] Early Treatment Response and Discontinuation Rates with Telaprevir and Boceprevir-based Triple Therapy in a Tertiary Care Liver Center
    Kanwar, Pushpjeet
    Hawkins, Tiffany
    Siddique, Asma
    Siekas, Lacey
    Wang, Chia
    Brulotte, Natalie
    Lee, Maximilian
    Murakami, Carol
    Kowdley, Kris
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S127 - S127
  • [9] Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir
    Moradpour, Darius
    Muellhaupt, Beat
    SWISS MEDICAL WEEKLY, 2012, 142
  • [10] Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C
    Petta, Salvatore
    Cabibbo, Giuseppe
    Enea, Marco
    Macaluso, Fabio Salvatore
    Plaia, Antonella
    Bruno, Raffaele
    Gasbarrini, Antonio
    Bruno, Savino
    Craxi, Antonio
    Camma, Calogero
    DIGESTIVE AND LIVER DISEASE, 2014, 46 (10) : 936 - 942
12345